共 171 条
[1]
DeSantis CE(2019)Breast cancer statistics, 2019 CA Cancer J Clin 69 438-451
[2]
Ma J(2012)Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project Jpn J Clin Oncol 42 139-147
[3]
Gaudet MM(2015)Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011 Breast Cancer. 22 235-244
[4]
Newman LA(2015)Breast cancer screening and the changing population pyramid of Japan Breast Cancer. 22 172-176
[5]
Miller KD(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
[6]
Goding Sauer A(2016)Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V J Clin Oncol 34 927-935
[7]
Matsuda T(2017)20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years N Engl J Med 377 1836-1846
[8]
Marugame T(2015)Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor Int J Clin Oncol. 20 249-252
[9]
Kamo K(2013)Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Lancet 381 805-816
[10]
Katanoda K(2005)Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17 J Natl Cancer Inst 97 1262-1271